Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.973 |
37 |
|
2002 |
2020 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
1.000 |
25 |
|
2008 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
1.000 |
18 |
|
2009 |
2019 |
Multiple congenital anomalies
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Congenital Abnormality
|
251
|
350
|
0.100 |
None |
1.000 |
11 |
1
|
2008 |
2017 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2780
|
385
|
0.380 |
None |
1.000 |
8 |
|
2002 |
2015 |
Intellectual Disability
|
group |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
2165
|
159
|
0.130 |
None |
1.000 |
3 |
|
2017 |
2019 |
Carcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2462
|
103
|
0.020 |
None |
1.000 |
2 |
|
2009 |
2016 |
Neurodevelopmental Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
535
|
14
|
0.310 |
None |
1.000 |
2 |
|
2017 |
2017 |
MYELODYSPLASTIC SYNDROME
|
group |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1033
|
95
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2018 |
Esophageal Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1254
|
270
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Immunologic Deficiency Syndromes
|
group |
Immune System Diseases
|
Disease or Syndrome
|
973
|
31
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Inflammatory Bowel Diseases
|
group |
Digestive System Diseases
|
Disease or Syndrome
|
1577
|
605
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Precancerous Conditions
|
group |
Neoplasms
|
Neoplastic Process
|
471
|
18
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Stomach Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
820
|
55
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Adult Solid Neoplasm
|
group |
|
Neoplastic Process
|
163
|
3
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Hematologic Neoplasms
|
group |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
827
|
60
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Brain Stem Neoplasms
|
group |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
8
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Pontine Tumors
|
group |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
4
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Secondary Neoplasm
|
group |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2492
|
85
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.100 |
None |
1.000 |
18 |
|
2005 |
2019 |
Muscle hypotonia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Finding
|
967
|
579
|
0.100 |
None |
1.000 |
11 |
1
|
2008 |
2017 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.080 |
None |
1.000 |
8 |
|
2014 |
2020 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.080 |
None |
1.000 |
8 |
|
2014 |
2019 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.020 |
None |
1.000 |
2 |
|
2003 |
2011 |
Developmental delay (disorder)
|
phenotype |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
584
|
68
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2019 |